StockDuty ← Dashboard Nov 15, 2026 11:56 AM ET
SignalEarnings

$CVS (CVS HEALTH) — 8-K: CVS Q3 FY26: Adj EPS $2.09 beats Street's $1.65 by 26.6%; FY26 guide raised

CVS
$89.35
-0.49%
Adjusted EPS of $2.09 topped the $1.65 consensus by $0.44 (+26.6%). Total revenues rose 5.4% YoY to $108,399M, with full-year 2026 Adjusted EPS guidance raised to at least $8.20 from $7.90–$8.10 and GAAP diluted EPS to at least $6.98. The beat was driven by improved adjusted operating income in the Health Care Benefits segment on continued execution of its margin recovery plan, with MBR improving to 91.3% from 92.8%.
Adjusted EPS of $2.09 topped the $1.65 consensus by $0.44 (+26.6%). Total revenues rose 5.4% YoY to $108,399M, with full-year 2026 Adjusted EPS guidance raised to at least $8.20 from $7.90–$8.10 and G
Sources